Ir al contenido

Wikiproyecto:Medicina/Cochrane/Revisiones Cochrane en es.Wikipedia/Cochrane Cancer

De Wikipedia, la enciclopedia libre
  Bienvenida   ¿Cómo editar?   ¿Cómo empezar?   Revisiones Cochrane en Wikipedia Español   Resúmenes en términos sencillos   [Biblioteca Cochrane|Biblioteca Cochrane]   ¿Preguntas?  

Cochrane Cancer:
Revisiones que pueden ser consideradas para Wikipedia


Breast Cancer Group[editar]

01/10/2012 Postoperative tamoxifen for ductal carcinoma in situ PMID:23076938.0 https://doi.org/10.1002/14651858.CD007847.pub2

01/10/2012 Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients PMID:23076939.0 https://doi.org/10.1002/14651858.CD007913.pub2

01/12/2020 Body weight management in overweight and obese breast cancer survivors PMID:33305350.0 https://doi.org/10.1002/14651858.CD012110.pub2

01/10/2020 Platinum-containing regimens for triple-negative metastatic breast cancer PMID:33084020.0 https://doi.org/10.1002/14651858.CD013750

01/04/2020 Indocyanine green angiography for preventing postoperative mastectomy skin flap necrosis in immediate breast reconstruction PMID:32320056.0 https://doi.org/10.1002/14651858.CD013280.pub2

01/03/2020 Ovarian suppression for adjuvant treatment of hormone receptor-positive early breast cancer PMID:32141074.0 https://doi.org/10.1002/14651858.CD013538

01/01/2020 Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer PMID:31994181.0 https://doi.org/10.1002/14651858.CD012988.pub2

01/09/2019 Taxanes for adjuvant treatment of early breast cancer PMID:31476253.0 https://doi.org/10.1002/14651858.CD004421.pub3

01/04/2019 Risk-reducing medications for primary breast cancer: a network meta-analysis PMID:31032883.0 https://doi.org/10.1002/14651858.CD012191.pub2

01/03/2019 Mindfulness-based stress reduction for women diagnosed with breast cancer PMID:30916356.0 https://doi.org/10.1002/14651858.CD011518.pub2

01/02/2019 Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment PMID:30779124.0 https://doi.org/10.1002/14651858.CD011433.pub2

01/02/2019 Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer PMID:30776132.0 https://doi.org/10.1002/14651858.CD012873.pub2

01/04/2018 Risk-reducing mastectomy for the prevention of primary breast cancer PMID:29620792.0 https://doi.org/10.1002/14651858.CD002748.pub4

01/03/2018 Breast surgery for metastatic breast cancer PMID:29542106.0 https://doi.org/10.1002/14651858.CD011276.pub2

01/01/2018 Physical activity for women with breast cancer after adjuvant therapy PMID:29376559.0 https://doi.org/10.1002/14651858.CD011292.pub2

01/08/2017 Home-based multidimensional survivorship programmes for breast cancer survivors PMID:28836379.0 https://doi.org/10.1002/14651858.CD011152.pub2

01/06/2017 Platinum-containing regimens for metastatic breast cancer PMID:28643430.0 https://doi.org/10.1002/14651858.CD003374.pub4

01/03/2017 Online support groups for women with breast cancer PMID:28278559.0 https://doi.org/10.1002/14651858.CD011652.pub2

01/02/2017 Interventions for raising breast cancer awareness in women PMID:28185268.0 https://doi.org/10.1002/14651858.CD011396.pub2

01/01/2017 Axillary treatment for operable primary breast cancer PMID:28052186.0 https://doi.org/10.1002/14651858.CD004561.pub3

01/01/2017 Fulvestrant for hormone-sensitive metastatic breast cancer PMID:28043088.0 https://doi.org/10.1002/14651858.CD011093.pub2

01/01/2017 Yoga for improving health-related quality of life, mental health and cancer-related symptoms in women diagnosed with breast cancer PMID:28045199.0 https://doi.org/10.1002/14651858.CD010802.pub2

01/09/2016 Exercise for women receiving adjuvant therapy for breast cancer PMID:27650122.0 https://doi.org/10.1002/14651858.CD005001.pub3

01/07/2016 Partial breast irradiation for early breast cancer PMID:27425375.0 https://doi.org/10.1002/14651858.CD007077.pub3

01/07/2016 Fraction size in radiation therapy for breast conservation in early breast cancer PMID:27425588.0 https://doi.org/10.1002/14651858.CD003860.pub4

01/05/2016 High-dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer PMID:27200512.0 https://doi.org/10.1002/14651858.CD003139.pub3

01/05/2016 Different types of implants for reconstructive breast surgery PMID:27182693.0 https://doi.org/10.1002/14651858.CD010895.pub2

01/05/2016 Follow-up strategies for women treated for early breast cancer PMID:27230946.0 https://doi.org/10.1002/14651858.CD001768.pub3

01/06/2015 Taxane-containing regimens for metastatic breast cancer PMID:26058962.0 https://doi.org/10.1002/14651858.CD003366.pub3

01/05/2015 Psychological interventions for women with non-metastatic breast cancer PMID:26017383.0 https://doi.org/10.1002/14651858.CD008729.pub2

01/02/2015 Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy PMID:25677413.0 https://doi.org/10.1002/14651858.CD009765.pub2

01/06/2014 Trastuzumab-containing regimens for metastatic breast cancer PMID:24919460.0 https://doi.org/10.1002/14651858.CD006242.pub2

01/05/2014 Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) PMID:nan https://doi.org/10.1002/14651858.CD004272.pub3

01/06/2013 Psychological interventions for women with metastatic breast cancer PMID:23737397.0 https://doi.org/10.1002/14651858.CD004253.pub4

01/05/2013 Fibrin glue instillation under skin flaps to prevent seroma-related morbidity following breast and axillary surgery PMID:23728694.0 https://doi.org/10.1002/14651858.CD009557.pub2

01/04/2013 Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk PMID:23633376.0 https://doi.org/10.1002/14651858.CD009632.pub2

01/04/2013 Sequencing of chemotherapy and radiotherapy for early breast cancer PMID:23633328.0 https://doi.org/10.1002/14651858.CD005212.pub3

01/07/2012 Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer PMID:22786517.0 https://doi.org/10.1002/14651858.CD008941.pub2

01/07/2012 Toremifene versus tamoxifen for advanced breast cancer PMID:22786516.0 https://doi.org/10.1002/14651858.CD008926.pub2

01/04/2012 Trastuzumab containing regimens for early breast cancer PMID:22513938.0 https://doi.org/10.1002/14651858.CD006243.pub2

01/02/2012 Cancer genetic risk assessment for individuals at risk of familial breast cancer PMID:22336791.0 https://doi.org/10.1002/14651858.CD003721.pub3

01/05/2011 Timing of breast surgery in premenopausal breast cancer patients PMID:21563138.0 https://doi.org/10.1002/14651858.CD003720.pub2

01/12/2012 Multidisciplinary rehabilitation for follow-up of women treated for breast cancer PMID:23235677.0 https://doi.org/10.1002/14651858.CD009553.pub2

01/10/2013 Wound drainage after axillary dissection for carcinoma of the breast PMID:24158902.0 https://doi.org/10.1002/14651858.CD006823.pub2

01/11/2013 Post-operative radiotherapy for ductal carcinoma in situ of the breast PMID:24259251.0 https://doi.org/10.1002/14651858.CD000563.pub7

01/12/2013 Combination versus sequential single agent chemotherapy for metastatic breast cancer PMID:24347031.0 https://doi.org/10.1002/14651858.CD008792.pub2

01/12/2015 Localization techniques for guided surgical excision of non-palpable breast lesions PMID:26718728.0 https://doi.org/10.1002/14651858.CD009206.pub2

01/11/2016 Nipple- and areola-sparing mastectomy for the treatment of breast cancer PMID:27898991.0 https://doi.org/10.1002/14651858.CD008932.pub3

01/10/2017 Bisphosphonates and other bone agents for breast cancer PMID:29082518.0 https://doi.org/10.1002/14651858.CD003474.pub4

01/11/2017 Tumour bed boost radiotherapy for women after breast-conserving surgery PMID:29105051.0 https://doi.org/10.1002/14651858.CD011987.pub2

Childhood Cancer Group[editar]

01/03/2020 Severe fatigue after treatment for childhood cancer PMID:32124971.0 https://doi.org/10.1002/14651858.CD012681.pub2

01/01/2020 Different infusion durations for preventing platinum-induced hearing loss in children with cancer PMID:31961948.0 https://doi.org/10.1002/14651858.CD010885.pub5

01/05/2019 Medical interventions for the prevention of platinum-induced hearing loss in children with cancer PMID:31063591.0 https://doi.org/10.1002/14651858.CD009219.pub5

01/04/2019 Hepatic late adverse effects after antineoplastic treatment for childhood cancer PMID:30985922.0 https://doi.org/10.1002/14651858.CD008205.pub3

01/04/2019 Anti-GD2 antibody-containing immunotherapy postconsolidation therapy for people with high-risk neuroblastoma treated with autologous haematopoietic stem cell transplantation PMID:31016728.0 https://doi.org/10.1002/14651858.CD012442.pub2

01/03/2019 Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer PMID:30855726.0 https://doi.org/10.1002/14651858.CD008944.pub3

01/08/2017 Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation PMID:28840597.0 https://doi.org/10.1002/14651858.CD010685.pub3

01/04/2017 Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma PMID:28429876.0 https://doi.org/10.1002/14651858.CD010349.pub2

01/03/2017 Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer PMID:28272834.0 https://doi.org/10.1002/14651858.CD006945.pub4

01/08/2016 Nutritional interventions for survivors of childhood cancer PMID:27545902.0 https://doi.org/10.1002/14651858.CD009678.pub2

01/08/2016 Platinum-induced hearing loss after treatment for childhood cancer PMID:27486906.0 https://doi.org/10.1002/14651858.CD010181.pub2

01/08/2016 Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer PMID:27552363.0 https://doi.org/10.1002/14651858.CD008011.pub3

01/06/2016 Radiotherapy for diffuse brainstem glioma in children and young adults PMID:27378212.0 https://doi.org/10.1002/14651858.CD010439.pub2

01/04/2016 Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia PMID:27107610.0 https://doi.org/10.1002/14651858.CD006247.pub3

01/03/2016 Physical exercise training interventions for children and young adults during and after treatment for childhood cancer PMID:27030386.0 https://doi.org/10.1002/14651858.CD008796.pub3

01/02/2016 Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia PMID:26899263.0 https://doi.org/10.1002/14651858.CD008382.pub2

01/02/2016 Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood PMID:26836199.0 https://doi.org/10.1002/14651858.CD007786.pub3

01/01/2016 Antibody therapies for lymphoma in children PMID:26784573.0 https://doi.org/10.1002/14651858.CD011181.pub2

01/09/2015 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma PMID:26417712.0 https://doi.org/10.1002/14651858.CD009263.pub2

01/09/2015 Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients PMID:26421585.0 https://doi.org/10.1002/14651858.CD006300.pub4

01/08/2015 Nutritional support in children and young people with cancer undergoing chemotherapy PMID:26301790.0 https://doi.org/10.1002/14651858.CD003298.pub3

01/05/2015 Rapid COJEC versus standard induction therapies for high-risk neuroblastoma PMID:25989478.0 https://doi.org/10.1002/14651858.CD010774.pub2

01/01/2015 Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children PMID:25560834.0 https://doi.org/10.1002/14651858.CD008403.pub3

01/01/2015 Chemotherapy for children with medulloblastoma PMID:25879092.0 https://doi.org/10.1002/14651858.CD006678.pub2

01/09/2014 Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer PMID:25188452.0 https://doi.org/10.1002/14651858.CD006647.pub4

01/09/2013 Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters PMID:24026801.0 https://doi.org/10.1002/14651858.CD009160.pub2

01/08/2013 Influenza vaccination in children being treated with chemotherapy for cancer PMID:23904194.0 https://doi.org/10.1002/14651858.CD006484.pub3

01/06/2013 Antibiotic and other lock treatments for tunnelled central venous catheter-related infections in children with cancer PMID:23799867.0 https://doi.org/10.1002/14651858.CD008975.pub2

01/05/2011 Methotrexate for high-grade osteosarcoma in children and young adults PMID:21563152.0 https://doi.org/10.1002/14651858.CD006325.pub3

01/10/2015 High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma PMID:26436598.0 https://doi.org/10.1002/14651858.CD006301.pub4

01/12/2015 Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients PMID:26666580.0 https://doi.org/10.1002/14651858.CD009759.pub3

01/12/2015 Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients PMID:26666581.0 https://doi.org/10.1002/14651858.CD009898.pub3

01/11/2016 Interventions for promoting participation in shared decision-making for children with cancer PMID:27898175.0 https://doi.org/10.1002/14651858.CD008970.pub3

01/11/2017 Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia PMID:29106702.0 https://doi.org/10.1002/14651858.CD008727.pub4

Gynaecological, Neuro-oncology and Orphan Cancer Group[editar]

01/10/2011 Adjuvant chemotherapy for endometrial cancer after hysterectomy PMID:21975736.0 https://doi.org/10.1002/14651858.CD003175.pub2

01/12/2011 Interventions for reducing anxiety in women undergoing colposcopy PMID:22161395.0 https://doi.org/10.1002/14651858.CD006013.pub3

01/10/2012 Chemotherapy for metastatic and recurrent cervical cancer PMID:23076924.0 https://doi.org/10.1002/14651858.CD006469.pub2

01/11/2012 Psychosocial interventions to improve quality of life and emotional wellbeing for recently diagnosed cancer patients PMID:23152241.0 https://doi.org/10.1002/14651858.CD007064.pub2

01/12/2012 Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer PMID:23235641.0 https://doi.org/10.1002/14651858.CD007406.pub3

01/10/2013 Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer PMID:24142521.0 https://doi.org/10.1002/14651858.CD010482.pub2

01/10/2013 Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients PMID:24105485.0 https://doi.org/10.1002/14651858.CD003992.pub3

01/10/2013 Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer PMID:24085528.0 https://doi.org/10.1002/14651858.CD006651.pub3

01/11/2013 Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy PMID:24282062.0 https://doi.org/10.1002/14651858.CD009896.pub2

01/11/2013 Follow-up protocols for women with cervical cancer after primary treatment PMID:24277645.0 https://doi.org/10.1002/14651858.CD008767.pub2

01/11/2013 Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients PMID:24277633.0 https://doi.org/10.1002/14651858.CD003295.pub3

01/11/2013 Patient-reported outcome measures for follow-up after gynaecological cancer treatment PMID:24249483.0 https://doi.org/10.1002/14651858.CD010299.pub2

01/12/2013 Surgery for cervical intraepithelial neoplasia PMID:24302546.0 https://doi.org/10.1002/14651858.CD001318.pub3

01/12/2013 Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia PMID:24302533.0 https://doi.org/10.1002/14651858.CD001421.pub3

01/10/2014 Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients PMID:25269391.0 https://doi.org/10.1002/14651858.CD005590.pub3

01/10/2014 Colony-stimulating factors for chemotherapy-induced febrile neutropenia PMID:25356786.0 https://doi.org/10.1002/14651858.CD003039.pub2